March 05, 2018
Safety Analysis of Leishmania Vaccine Used in a Randomized Canine Vaccine/Immunotherapy Trial
In Leishmania infantum–endemic countries, controlling infection within dogs, the domestic reservoir, is critical to public health. There is a need for safe vaccines that prevent canine progression with disease and transmission to others. Protective vaccination against Leishmania requires mounting a strong, inflammatory, Type 1 response. Three commercially available canine vaccines on the global veterinary market use saponin or inflammatory antigen components (Letifend) as a strong pro-inflammatory adjuvant. There is very little information detailing safety of saponin as an adjuvant in field trials. Safety analyses for the use of vaccine as an immunotherapeutic in asymptomatically infected animals are completely lacking. Leishmania infantum, the causative agent of canine leishmaniasis, is enzootic within U.S. hunting hounds. We assessed the safety of LeishTec® after use in dogs from two different clinical states: 1) without clinical signs and tested negative on polymerase chain reaction and serology or 2) without clinical signs and positive for at least one Leishmania diagnostic test. Vaccine safety was assessed after all three vaccinations to quantify the number and severity of adverse events. Vaccinated animals had an adverse event rate of 3.09%, whereas placebo animals had 0.68%. Receiving vaccine was correlated with the occurrence of mild, site-specific, reactions. Occurrence of severe adverse events was not associated with having received vaccine. Infected, asymptomatic animals did not have a higher rate of adverse events. Use of vaccination is, therefore, likely to be safe in infected, asymptomatic animals.
Read the full article in The American of Tropical Medicine and Hygiene.
More from CNAS
-
Bombshell: Come What May
Podcast
Erin, Radha, and Loren invited Dr. Lindsay Cohn of the U.S. Naval War College to join their posse and explain America’s history of employing the military for domestic purposes...
By Loren DeJonge Schulman, Lindsay Cohn, Radha Iyengar & Erin Simpson
-
Loren DeJonge Schulman on The Smell of Victory Podcast
Podcast
On The Smell of Victory Podcast, Bob Hein and Phil Walter sat down with Loren DeJonge Schulman of the Center for a New American Security to discuss the draft. Listen to the f...
By Loren DeJonge Schulman
-
Susanna V. Blume on Defense & Aerospace Report Podcast
Podcast
On this Roundtable episode of the Defense & Aerospace Report Podcast, sponsored by Bell, a Textron company, our guests include Bob Hale,(who now advises Booz Allen Hamilton &m...
By Susanna V. Blume
-
CNAS’ Colby on Nuclear Strategy, Deterrence, Developing New Capabilities, INF Treaty
Video
Bridge Colby, the former deputy assistant secretary of defense for strategy and force planning — one of the authors of the Pentagon’s National Defense Strategy — n...
By Elbridge Colby
